Fierce Biotech News & Reports
Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech ...
Fierce Biotech Layoff Tracker 2024
5 天之前 · Dec. 11 - Nvelop Therapeutics / Chroma Medicine: As part of their merger to form new Boston-based biotech nChroma Bio, both Nvelop and Chroma have shed an undisclosed number of employees.Story ...
Genentech inks $850M upfront deal for Regor's CDK inhibitors
2024年9月30日 · Genentech is paying $850 million upfront for Regor Pharmaceuticals’ portfolio of CDK inhibitors, taking ownership of a breast cancer candidate that has shown signs of single-agent efficacy in ...
Introducing Fierce Biotech's 2024 Fierce 15
2024年8月5日 · One of our Fierce 15 honorees dove deep into the ocean for inspiration from the sea squirt to develop new human therapeutics. Another thought the adorable 13-lined ground squirrel, with its polka ...
Biotech | Fierce Biotech
2024年10月28日 · Since the biotech shared the phase 3 data this morning, the company’s stock has dropped 54%, from $2 per share to 92 cents.
MedTech | Fierce Biotech
The deal, valued at about $9 million in cash to start, will see NeuroMetrix become an electroCore subsidiary.
Top 10 pharma R&D budgets in 2023 - Fierce Biotech
After nearly a decade as No. 1, Roche has finally been knocked off the top spot of our annual list of the biggest research and development budgets in pharma, sent spinning down the ladder by a ...
The 2024 Biotech Graveyard
2024年10月31日 · Beware: ghosts of biotech’s past. | Last year, biotech shutdowns spiked. Thankfully, 2024’s numbers are a little lower, dropping from the 27 closures in 2023 to 22 this year.
Cytovale gains momentum with $100M for its sepsis screening test
2024年10月10日 · Cytovale aims for its test to become as ubiquitous as urgent blood troponin screening for detecting heart attacks and cardiac damage, or CT scans for diagnosing strokes—while sepsis is more ...
Regeneron to fill gaps in obesity, break ground in cell therapy
2024年2月2日 · Regeneron wants to improve on obesity care with a muscle-preservation approach, while elsewhere, the biopharma charts a new course in cell therapy.